Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[For molecular imaging strategies, a putative panel consisting of markers for EGFR, IGF1-R, FGFR2, GLUT1, CAXII, CD44v6 was positive in 77% of cases and might be considered for development of molecular tracers for male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[For molecular imaging strategies, a putative panel consisting of markers for EGFR, IGF1-R, FGFR2, GLUT1, CAXII, CD44v6 was positive in 77% of cases and might be considered for development of molecular tracers for male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[For molecular imaging strategies, a putative panel consisting of markers for EGFR, IGF1-R, FGFR2, GLUT1, CAXII, CD44v6 was positive in 77% of cases and might be considered for development of molecular tracers for male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP276898.RAW9-z0mgB85Vqa30yYlMd88ZbA2OCog1UFJcmRm1b4y8130_assertion description "[For molecular imaging strategies, a putative panel consisting of markers for EGFR, IGF1-R, FGFR2, GLUT1, CAXII, CD44v6 was positive in 77% of cases and might be considered for development of molecular tracers for male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276898.RAW9-z0mgB85Vqa30yYlMd88ZbA2OCog1UFJcmRm1b4y8130_provenance.
• NP695816.RAa0hM7LRYrFVjNDRqWl2W_MaQKvqU9KiBMczDAtdiKyo130_assertion description "[For molecular imaging strategies, a putative panel consisting of markers for EGFR, IGF1-R, FGFR2, GLUT1, CAXII, CD44v6 was positive in 77% of cases and might be considered for development of molecular tracers for male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP695816.RAa0hM7LRYrFVjNDRqWl2W_MaQKvqU9KiBMczDAtdiKyo130_provenance.
• NP1042803.RAbuMCQ_UOyFWB9YZt09CwJ67egHBuUeINbPsNf6S7I_Q130_assertion description "[For molecular imaging strategies, a putative panel consisting of markers for EGFR, IGF1-R, FGFR2, GLUT1, CAXII, CD44v6 was positive in 77% of cases and might be considered for development of molecular tracers for male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1042803.RAbuMCQ_UOyFWB9YZt09CwJ67egHBuUeINbPsNf6S7I_Q130_provenance.
• NP1042811.RAfdUhJbqPc-D47gFGqzXkzjuEMefAYngvN6AcCQ9Qn7Y130_assertion description "[For molecular imaging strategies, a putative panel consisting of markers for EGFR, IGF1-R, FGFR2, GLUT1, CAXII, CD44v6 was positive in 77% of cases and might be considered for development of molecular tracers for male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1042811.RAfdUhJbqPc-D47gFGqzXkzjuEMefAYngvN6AcCQ9Qn7Y130_provenance.
• NP369437.RAlQTkuEAhPtgpq7FpH9FJvkaNgPNdBuEMZzwtE3UL-SU130_assertion description "[For molecular imaging strategies, a putative panel consisting of markers for EGFR, IGF1-R, FGFR2, GLUT1, CAXII, CD44v6 was positive in 77% of cases and might be considered for development of molecular tracers for male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP369437.RAlQTkuEAhPtgpq7FpH9FJvkaNgPNdBuEMZzwtE3UL-SU130_provenance.
• NP369490.RAGNm5FJQhHaR3-Id_tLzolR7umbsfGkdZgN7CeOP-K-A130_assertion description "[For molecular imaging strategies, a putative panel consisting of markers for EGFR, IGF1-R, FGFR2, GLUT1, CAXII, CD44v6 was positive in 77% of cases and might be considered for development of molecular tracers for male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP369490.RAGNm5FJQhHaR3-Id_tLzolR7umbsfGkdZgN7CeOP-K-A130_provenance.
• NP276897.RAIKM9r51vmO6PE-Q6oif0mZGVqyzJ9onmlLydrjX2qHU130_assertion description "[For molecular imaging strategies, a putative panel consisting of markers for EGFR, IGF1-R, FGFR2, GLUT1, CAXII, CD44v6 was positive in 77% of cases and might be considered for development of molecular tracers for male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276897.RAIKM9r51vmO6PE-Q6oif0mZGVqyzJ9onmlLydrjX2qHU130_provenance.
• NP695826.RAJsy5E4uZZe_m78gpklN72z0bXwcsf65Jibtviiu0u5Y130_assertion description "[For molecular imaging strategies, a putative panel consisting of markers for EGFR, IGF1-R, FGFR2, GLUT1, CAXII, CD44v6 was positive in 77% of cases and might be considered for development of molecular tracers for male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP695826.RAJsy5E4uZZe_m78gpklN72z0bXwcsf65Jibtviiu0u5Y130_provenance.
• NP1042806.RAOwCKy8dafxs3_GX4siuEx897dNlTl71TQ_YqE_je8wA130_assertion description "[For molecular imaging strategies, a putative panel consisting of markers for EGFR, IGF1-R, FGFR2, GLUT1, CAXII, CD44v6 was positive in 77% of cases and might be considered for development of molecular tracers for male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1042806.RAOwCKy8dafxs3_GX4siuEx897dNlTl71TQ_YqE_je8wA130_provenance.
• NP1042812.RAJHO-DACXpnEaa_9Og10ScJILOa7k0gNXXM0brwhQa2c130_assertion description "[For molecular imaging strategies, a putative panel consisting of markers for EGFR, IGF1-R, FGFR2, GLUT1, CAXII, CD44v6 was positive in 77% of cases and might be considered for development of molecular tracers for male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1042812.RAJHO-DACXpnEaa_9Og10ScJILOa7k0gNXXM0brwhQa2c130_provenance.
• NP1042810.RAwSfqdjA9U3UyYQXtBqGslLyDLgvH808WyUiTK_13oJs130_assertion description "[For molecular imaging strategies, a putative panel consisting of markers for EGFR, IGF1-R, FGFR2, GLUT1, CAXII, CD44v6 was positive in 77% of cases and might be considered for development of molecular tracers for male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1042810.RAwSfqdjA9U3UyYQXtBqGslLyDLgvH808WyUiTK_13oJs130_provenance.
• NP1042814.RA4SanJe2aMs0py-jxS33Z7JB4l86AfbycIseyHQ7xqg4130_assertion description "[For molecular imaging strategies, a putative panel consisting of markers for EGFR, IGF1-R, FGFR2, GLUT1, CAXII, CD44v6 was positive in 77% of cases and might be considered for development of molecular tracers for male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1042814.RA4SanJe2aMs0py-jxS33Z7JB4l86AfbycIseyHQ7xqg4130_provenance.